Who is sponsoring NCT03047499?

NCT03047499 is sponsored by Mostafa Khairy.

What drugs are being tested in NCT03047499?

Interventions in NCT03047499: Botulinum toxin type A.

Is NCT03047499 still recruiting?

NCT03047499 is currently status unknown. Last updated 9 February 2017.

Last reviewed 2017-02-09 · How we verify

NCT03047499

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleft Lip Repair by Modified Millard Cheiloplasty

Status unknown Last updated 9 February 2017

What this trial tests

trial testing Botulinum toxin type A in Esthetic Outcome of Injection of Botulinum Toxin Type-A in Cleft Lip Repair in 2 participants. Status unknown.

Timeline

15 February 2017

Primary endpoint
15 October 2017

15 November 2017

Quick facts

Lead sponsor	Mostafa Khairy
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	2
Start date	15 February 2017
Primary completion	15 October 2017
Estimated completion	15 November 2017
Sites	1 location across Egypt

Drugs / interventions tested

Botulinum toxin type A (BOTULINUM TOXIN TYPE A) — full drug profile →

Conditions studied

Esthetic Outcome of Injection of Botulinum Toxin Type-A in Cleft Lip Repair — all drugs for Esthetic Outcome of Injection of Botulinum Toxin Type-A in Cleft Lip Repair →

Sponsor

Mostafa Khairy

Who can join

Adults 3 Months to 6 Months, any sex, with Esthetic Outcome of Injection of Botulinum Toxin Type-A in Cleft Lip Repair. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the effect of botulinum toxin type-A injection prior to surgical correction of complete unilateral cleftlip repair by modified millard cheiloplasty

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Botulinum toxin type A

Trials testing the same drug.

NCT07236632 — Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized S · NA · not yet recruiting
NCT06448676 — Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides · Phase 4 · not yet recruiting
NCT06296082 — Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Sp · Phase 2, PHASE3 · recruiting
NCT06385171 — Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation · recruiting
NCT06465056 — Use of Botulinum Toxin A in Direct Eyebrow Lift Scar · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03047499 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mostafa Khairy
Last refreshed: 9 February 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03047499.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing